GlassScriptPhysician profile
Alexia K Ford
NPI 1215626601
$1,727.71
in general payments reported to CMS, 2019-2025
22 companies · $1,415 in 2025
The $1,415 reported for 2025 was more than what 88% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $226 · 2024: $86.65 · 2025: $1,415.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,601 · Education: $99.99 · Entertainment: $26.32.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,601.40 |
| Education | $99.99 |
| Entertainment | $26.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $452.24 | 2025 | Dupixent, Libtayo |
| Genzyme Corporation | $183.20 | 2025 | |
| Janssen Biotech, INC. | $163.80 | 2025 | Tremfya, Simponi Aria, Stelara |
| Leo Pharma INC. | $139.35 | 2025 | Adbry, Anzupgo |
| Novartis Pharmaceuticals Corporation | $121.26 | 2025 | |
| Pfizer INC. | $102.01 | 2023-2025 | |
| Organon LLC | $101.20 | 2025 | Vtama |
| Astrazeneca Pharmaceuticals LP | $63.38 | 2023-2024 | Farxiga, Breztri |
| Mayne Pharma Commercial LLC | $54.43 | 2025 | |
| Ucb, INC. | $51.89 | 2025 | Bimzelx |
| Novo Nordisk INC | $37.66 | 2023-2024 | Rybelsus, Ozempic |
| Baxter Healthcare | $33.42 | 2023 | Hillrom - Cardiac Ambulatory Monitor, Hillrom - Carnation Ambulatory Monitor |
| Abbvie INC. | $31.90 | 2024-2025 | |
| Kyowa Kirin, INC. | $29.68 | 2025 | |
| Gilead Sciences, INC. | $28.10 | 2023 | Epclusa |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $27.39 | 2023 | Mounjaro, Jardiance |
| Optos, INC. | $26.32 | 2023 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Verrica Pharmaceuticals INC. | $17.61 | 2025 | Ycanth |
| Bayer Healthcare Pharmaceuticals INC. | $17.55 | 2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $16.13 | 2023 | Xifaxan |
| Arcutis Biotherapeutics, INC. | $15.55 | 2025 | Zoryve |
| Almirall LLC | $13.64 | 2025 | Klisyri |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexia Ford listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.